Showing results (681-690 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|April 27, 2026
Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategiesDeborah Ikhile, Samuel Seidu, Damilola Omodara, et al.
The Lancet. Diabetes & Endocrinology|April 20, 2026
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trialToshimasa Yamauchi, Niels-Peter Becker, Christoffer Andersen Hagemann, et al.
The Lancet. Diabetes & Endocrinology|August 5, 2018
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trialWiebke Birnbaum, Louise Marshall, Ralf Werner, et al.
The Lancet. Diabetes & Endocrinology|May 7, 2015
Pleiotropic effects of type 2 diabetes management strategies on renal risk factorsMarcel H A Muskiet, Lennart Tonneijck, Mark M Smits, et al.
The Lancet. Diabetes & Endocrinology|March 6, 2016
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trialCyrus Cooper, Nicholas C Harvey, Nicholas J Bishop, et al.
The Lancet. Diabetes & Endocrinology|June 17, 2026
1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort studyDaniel B Leslie, Brian T Steffen, Eric Wise, et al.
The Lancet. Diabetes & Endocrinology|July 9, 2021
Nutritional intake and bone healthRené Rizzoli, Emmanuel Biver, Tara C Brennan-Speranza
The Lancet. Diabetes & Endocrinology|February 27, 2023
Mechanisms of ageing: growth hormone, dietary restriction, and metforminJansher Khan, Ida Pernicova, Kiran Nisar, et al.
The Lancet. Diabetes & Endocrinology|December 4, 2023
Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trialDavaasambuu Ganmaa, Polyna Khudyakov, Uyanga Buyanjargal, et al.
The Lancet. Diabetes & Endocrinology|July 22, 2014
Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study
Pageof 93